Subcutaneous chronic implantable defibrillation systems in humans
- 17 March 2012
- journal article
- review article
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 34 (3) , 325-332
Abstract
The recent introduction of subcutaneous implantable cardioverter defibrillator (S-ICD) has raised attention about the potential of this technology for clinical use in daily clinical practice. We review the methods and results of the four studies conducted in humans for approval of this innovative technology for daily practice. Two studies using a temporary S-ICD system (acute human studies) were conducted to search for an appropriate lead configuration and energy requirements. For this purpose, 4 S-ICD configurations were tested in 78 patients at the time of transvenous (TV)-ICD implantation. The optimal configuration was tested in 49 more patients to comparatively assess the subcutaneous defibrillation threshold (S-DFT) versus the standard TV-ICD. Long-term implants were evaluated in 55 patients using an implanted system (chronic human study). The acute humans studies led to an optimal S-ICD configuration comprising a parasternal electrode and left anterolateral thoracic pulse generator. Both configurations successfully terminated 98% of induced ventricular fibrillation (VF), but significantly higher energy levels were required with S-ICD than with TV-ICD systems (36.6 ± 19.8 J vs. 11.1 ± 8.5 J). In the chronic study, all 137 VF episodes induced at time of implant were detected with a 98% conversion rate. Two pocket infections and four lead revisions were required during 10 ± 1 months of follow-up. During this period, survival was 98%, and 12 spontaneous ventricular tachyarrhythmias were detected and treated by the device. These data show that the S-ICD systems here consistently detected and converted VF induced at time of implant as well as sustained ventricular tachyarrhythmias occurring during follow-up (248).Keywords
This publication has 36 references indexed in Scilit:
- A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac DeathJACC, 2008
- Implantable Cardioverter-Defibrillator Lead PerformanceCirculation, 2008
- The Frequency and Incremental Cost of Major Complications Among Medicare Beneficiaries Receiving Implantable Cardioverter-DefibrillatorsJACC, 2006
- Transvenous Pacing Leads and Systemic Thromboemboli in Patients With Intracardiac ShuntsCirculation, 2006
- Detection and management of animplantable cardioverter defibrillator lead failureJACC, 2003
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Implantable Cardioverter Defibrillator in a 4‐Month‐Old Infant with Cardiac Arrest Associated with a Vascular Heart TumorPacing and Clinical Electrophysiology, 2001
- Incidence of Perforation and Other Mechanical Complications During Dual Active FixationPacing and Clinical Electrophysiology, 1996
- Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: Implications for management and future system designAmerican Heart Journal, 1995
- Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator.Circulation, 1985